1. P596 Ustekinumab and anti-TNF agents are equally safe and effective in elderly Crohn's disease patients: A propensity adjusted multi-centre cohort study. (30th January 2023) Authors: Gebeyehu, G G; Broglio, G; Liu, E; Limdi, J K; Selinger, C; Fiske, J; Razsanskaite, V; Smith, P J; Flanagan, P K; Subramanian, S Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i723 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗